← All people

Other insiders

Andrew Guggenhime

Transactions disclosed by this reporting insider. Insider filers can be individuals or organisations.

Source last checked 2026-10-12 01:37 UTC. Reporting dates appear with the records.

Stock growth & value

Stocks linked to collected disclosures. Prices refresh in the background; the chart shows its actual price dates.

Latest stored close
$71.38
PCVX · 2026-10-09 · USD
Stock price change
+$27.57
+62.93% over the displayed dates
Chart dates
2025-10-13 – 2026-10-09
Completed daily price dates

Stock price · move across the chart or use arrow keys

Oct 13, 2025Oct 9, 2026
Starting investment
$10K
2025-10-13 · hypothetical
Investment value
$16.3K
As of 2026-10-09
Estimated gain / loss
+$6,293.08
+62.93%

Illustration assumes buying this stock at the first displayed close and holding through the last. It does not represent this person's investment or earnings. Uses stored split-adjusted closing prices, without dividends, fees or taxes. Only mapped USD share positions qualify for firm estimates; options, debt and unmapped holdings are excluded. This chart covers the selected stock.

Collected Form 4 activity · 2026-07-06 – 2026-09-08. Priced non-derivative purchases and sales, including scheduled trades; excludes grants, exercises and tax withholding. These totals do not change with the chart period.

Disclosed purchases
—
No priced purchase collected
Disclosed sales
$1.1M
Sale proceeds, not profit

11 transaction lines

SEC Form 4 records. Grants, exercises, tax withholding and scheduled sales retain their labels.

CompanyActionValue
PCVXVaxcyte Inc2026-09-08
Withheld for tax
$431.9K
PCVXVaxcyte Inc2026-09-02
Withheld for tax
$88.2K
PCVXVaxcyte Inc2026-08-31
Withheld for tax
$77.3K
PCVXVaxcyte Inc2026-08-03
Option exercise10b5-1 plan
$53.5K
PCVXVaxcyte Inc2026-08-03
Sale10b5-1 plan
$374K
PCVXVaxcyte Inc2026-08-03
Sale10b5-1 plan
$164.9K
PCVXVaxcyte Inc2026-08-03
Option exercisederivative10b5-1 plan
—
PCVXVaxcyte Inc2026-07-06
Option exercise10b5-1 plan
$53.5K
PCVXVaxcyte Inc2026-07-06
Sale10b5-1 plan
$452.3K
PCVXVaxcyte Inc2026-07-06
Sale10b5-1 plan
$120.6K
PCVXVaxcyte Inc2026-07-06
Option exercisederivative10b5-1 plan
—

Original sources

Related datasets